Form D · Biotechnology

ECM Therapeutics, Inc.

Warrendale, PA · CIK 0001743104

Offering snapshot reported Oct 10, 2025 · SEC filing

Reported sold
$35.2M
Offering amount: $40M
Investors reported
190
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 28, 2018
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$17.6M$35.2MJun 8, 2018: $919,000.00Jun 8, 2018Jun 18, 2019: $2,443,500.00Sep 18, 2019: $6,500,000.00Sep 14, 2022: $15,924,006.00Jun 9, 2023: $21,044,006.00May 30, 2024: $26,100,000.00Oct 10, 2025: $35,219,000.00Oct 10, 2025

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$26,100,000 → $35,219,000
  • Reported investors138 → 190

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 10, 2025Amendment$35,219,000$9,119,000vs May 30, 2024190SEC filing
May 30, 2024Amendment$26,100,000$5,055,994vs Jun 9, 2023138SEC filing
Jun 9, 2023Amendment$21,044,006$5,120,000vs Sep 14, 2022182SEC filing
Sep 14, 2022Amendment$15,924,006$9,424,006vs Sep 18, 2019147SEC filing
Jul 30, 2021Amendment$10,091,006No comparisonNot reportedSEC filing
Sep 18, 2019Amendment$6,500,000$4,056,500vs Jun 18, 201973SEC filing
Jun 18, 2019Amendment$2,443,500$1,524,500vs Jun 8, 201831SEC filing
Jun 8, 2018Initial$919,000No comparison7SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-314165

Source: Form D, filed Oct 10, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Stephen Badylak Director, Executive
Katie Collins Director, Executive
Jenna Dziki Executive
Paul F. Fagan Director, Executive
George Hussey Executive
Lindsey Saldin Executive
Christine Sheehy Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
118 Marshall Drive
Warrendale, PA, 15086